Ogeda (alias Euroscreen) is a ULB spin-off created in 1994, and specialising in G-Protein Coupled Receptors (GPCR) used in pharmacological response. The company runs its own research programmes in order to identify and develop candidates for original medication, particularly for use in the fields of metabolism, inflammation, and female health (e.g. endometriosis).

Ogeda also provides cell line screening services and works in partnership with various pharmaceutical companies (Pfizer, BoehringerIngleheim, Novartis Pharma AG, etc.) who find commercial applications for its research.

Rue Adrienne Bolland 47,
B-6041 Gosselies.
T. +32 (0)71 34 85 00
F. +32 (0)71 34 85 19